The Prostate Cancer Foundation (PCF) and Pfizer Inc. Independent Medical Education Visiting Professorship Program supports community-based urology and medical oncology organizations in implementing germline and somatic testing for precision medicine in prostate cancer care. This competitive grant program provides financial support for approved organizations to host a 2.5-to-3-hour medical education program led by one or two Visiting Professors whose expertise aligns with the organization's unmet educational and practice needs related to genetic and somatic testing for patients with prostate cancer.

Overview

This first-time competitive Visiting Professorship program aims to provide meaningful education for prostate cancer care teams in community practice, building capacity by helping teams identify gaps in patient care, engineer practice-level solutions, and foster collaborations between community-based practitioners and academic experts. The program is designed to help initiate or implement a practice-level solution that improves the delivery of prostate cancer care at the grantee site, specifically addressing practice gaps related to germline and somatic testing. Urologists, medical oncologists, advanced practice providers, and patients benefit from the knowledge and onsite presence of distinguished clinical experts who might otherwise be inaccessible.

The program is administered through a publicly posted Request for Proposals (RFP) with a scientific review committee (SRC) making final grant decisions. Organizations submit applications addressing specific gaps in practice or care as outlined in the RFP.

Eligibility

Eligible candidates include:

• Applicants must hold a medical degree (MD, DO, MBBS, NP or equivalent) and serve as a urologist or medical oncologist seeing patients with prostate cancer.
• Applicants must be an employee or independent contractor of the requesting Organization.
• The requesting Organization must be a urology and/or medical oncology organization providing care for patients with prostate cancer.
• Applicants should serve as Chair of the proposed medical education program and play a lead role in implementation.
• Only community-based urology or medical oncology practices (Organizations) are eligible to receive Grants.
• The Organization and hosting team must be located in the United States.
• The education program may include participants from multiple clinical specialties or service areas within the Organization as long as all participants have a relevant role and educational need.
• The Organization must be legally able to receive award funding directly from Pfizer Inc.

Funding and Benefits

The total budget for this RFP is $250,000 USD, with plans to support 5 to 7 organizations. Individual project budgets should not exceed $50,000 USD. The amount of the award depends upon the SRC's evaluation of the proposal and costs involved and will be stated clearly in the award agreement.

PCF will cover all medical education meeting expenses, including room rental if required, meals, and audiovisual equipment, as well as travel expenses and honoraria for Visiting Professors. These costs should not be included in the applicant's budget. Local costs such as onsite management, logistics, staff time, planning, and other implementation or initiation costs should be included in the budget proposal.

Pfizer may support up to 28% of overhead costs associated with the total proposed project budget.

In 2027, PCF will provide registration and travel support for one participant per Organization to attend the PCF Scientific Retreat, the world's foremost scientific conference on prostate cancer biology and treatment, held annually in autumn.

Application Process

Applications are submitted through the online portal at https://www.cybergrants.com/pfizer/knowledge. First-time users should create a password. In the application, under Program Overview, select "Support for a Visiting Professorship" for the question "What type of request are you submitting?" and select "Yes" for "Are you replying to a Request for Proposal as part of the Competitive Grant Program?" Select the Competitive Grant Program Name: 2026 ONC US PCF Visiting Professorship and the Primary Area of Interest: Oncology – Genitourinary; select Genitourinary – Prostate for the Cancer Type Detail question.

Applications must include a project proposal (single-spaced, Calibri 12-point font, 1-inch margins, 15-page limit exclusive of references) addressing: goals and objectives, needs assessment, project design and methods, innovation, evaluation and outcomes, participation in PCF Scientific Retreat, participation in video interviews, anticipated project timeline, additional information, organization detail, and budget detail with narrative.

A line-item budget must be included for all local costs. PCF will work with awardees on the program location, which may be onsite or offsite nearby.

Applications will be reviewed by a scientific review committee (SRC). If approved, the Institution will be required to enter into a written grant agreement with Pfizer. Applicants should review the core terms of the agreement prior to submission.

Deadline and Timeline

• RFP Release Date: April 24, 2026
• Grant Application Due: June 23, 2026 (23:59 Eastern Time, New York, GMT -5)
• Review of Applications by SRC: July – August 2026
• Anticipated Grant Award Notification: September – October 2026
• Anticipated Project Start and End Dates: November 1, 2026 – May 1, 2027

Applications submitted after the due date will not be reviewed.

Contact Information

Questions regarding this RFP should be directed to Ari Karon (akaron@pcf.org) and Lori Carpenter (lori.carpenter@pfizer.com) with the subject line: 2026 ONC US PCF Visiting Professorship.